Skye Bioscience, Inc.

Historical 13F Holders

Symbol
SKYE
CUSIP
83086J200
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 83086J200 since 12/18/2024, largest first.

Filer % of Class Filed
5AM Partners VII, LLC 13D/A
30.2% 8/18/2026
Event 8/14/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Sphera Funds Management Ltd. 13G/A
4.8% 4/10/2025
Event 3/31/2025
Schonfeld Strategic Advisors LLC 13G/A 3.6% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 44 16.0 M $11.1 M
2026 Q1 41 16.1 M $9.91 M
2025 Q4 52 16.1 M $12.1 M
2025 Q3 66 19.9 M $78.1 M
2025 Q2 65 20.4 M $85.3 M
2025 Q1 79 24.7 M $39.3 M
2024 Q4 75 25.2 M $71.3 M
2024 Q3 79 25.7 M $101 M
2024 Q2 68 25.8 M $207 M
2024 Q1 4 2.01 M $31.4 M
2023 Q4 1 1.60 k $4.35 k